WILHELMUS CM GROENHUYSEN Insider Trading for September 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILHELMUS CM GROENHUYSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of WILHELMUS CM GROENHUYSEN for September 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Option Exercise | M | 7.03 | 1,961 | 13,786 | 58,286 | |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Option Exercise | M | 7.03 | 1,961 | 13,786 | 58,286 | |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Option Exercise | M | 3.44 | 4,031 | 13,867 | 90,632 | |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Option Exercise | M | 3.44 | 4,031 | 13,867 | 90,632 | |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Option Exercise | M | 3.44 | 2,000 | 6,880 | 27,069 | |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Option Exercise | M | 3.44 | 2,000 | 6,880 | 27,069 | |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 81.19 | 300 | 24,358 | 87,179 | 87.5 K to 87.2 K (-0.34 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 81.19 | 300 | 24,358 | 87,179 | 87.5 K to 87.2 K (-0.34 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 80.56 | 1,661 | 133,804 | 87,479 | 89.1 K to 87.5 K (-1.86 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 80.56 | 1,661 | 133,804 | 87,479 | 89.1 K to 87.5 K (-1.86 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Buy | M | 7.03 | 1,961 | 13,786 | 89,140 | 87.2 K to 89.1 K (+2.25 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Buy | M | 7.03 | 1,961 | 13,786 | 89,140 | 87.2 K to 89.1 K (+2.25 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 81.18 | 700 | 56,824 | 87,179 | 87.9 K to 87.2 K (-0.80 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 81.18 | 700 | 56,824 | 87,179 | 87.9 K to 87.2 K (-0.80 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 80.50 | 3,331 | 268,155 | 87,879 | 91.2 K to 87.9 K (-3.65 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 80.50 | 3,331 | 268,155 | 87,879 | 91.2 K to 87.9 K (-3.65 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Buy | M | 3.44 | 4,031 | 13,867 | 91,210 | 87.2 K to 91.2 K (+4.62 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Buy | M | 3.44 | 4,031 | 13,867 | 91,210 | 87.2 K to 91.2 K (+4.62 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 81.19 | 300 | 24,358 | 87,179 | 87.5 K to 87.2 K (-0.34 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 81.19 | 300 | 24,358 | 87,179 | 87.5 K to 87.2 K (-0.34 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 80.53 | 1,700 | 136,899 | 87,479 | 89.2 K to 87.5 K (-1.91 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 80.53 | 1,700 | 136,899 | 87,479 | 89.2 K to 87.5 K (-1.91 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Buy | M | 3.44 | 2,000 | 6,880 | 89,179 | 87.2 K to 89.2 K (+2.29 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Buy | M | 3.44 | 2,000 | 6,880 | 89,179 | 87.2 K to 89.2 K (+2.29 %) |
Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 25,000 | 86,000 | 94,663 | |
Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 25,000 | 86,000 | 119,663 | |
Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 79.01 | 22,300 | 1,761,856 | 87,179 | 109.5 K to 87.2 K (-20.37 %) |
Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 78.33 | 2,700 | 211,478 | 109,479 | 112.2 K to 109.5 K (-2.41 %) |
Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 25,000 | 86,000 | 112,179 | 87.2 K to 112.2 K (+28.68 %) |
Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.96 | 400 | 32,384 | 87,179 | 87.6 K to 87.2 K (-0.46 %) |
Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.27 | 13,502 | 1,083,792 | 87,579 | 101.1 K to 87.6 K (-13.36 %) |
Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 79.24 | 11,098 | 879,372 | 101,081 | 112.2 K to 101.1 K (-9.89 %) |
Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 25,000 | 86,000 | 112,179 | 87.2 K to 112.2 K (+28.68 %) |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 25,000 | 86,000 | 144,663 | |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 25,000 | 86,000 | 169,663 | |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.05 | 201 | 16,291 | 87,179 | 87.4 K to 87.2 K (-0.23 %) |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.51 | 10,107 | 813,694 | 87,380 | 97.5 K to 87.4 K (-10.37 %) |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 79.42 | 6,499 | 516,151 | 97,487 | 104 K to 97.5 K (-6.25 %) |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 78.50 | 8,193 | 643,142 | 103,986 | 112.2 K to 104 K (-7.30 %) |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 25,000 | 86,000 | 112,179 | 87.2 K to 112.2 K (+28.68 %) |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 79.19 | 4,061 | 321,599 | 87,179 | 91.2 K to 87.2 K (-4.45 %) |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 78.72 | 11,015 | 867,057 | 91,240 | 102.3 K to 91.2 K (-10.77 %) |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 77.52 | 4,008 | 310,692 | 102,255 | 106.3 K to 102.3 K (-3.77 %) |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 76.37 | 3,974 | 303,478 | 106,263 | 110.2 K to 106.3 K (-3.60 %) |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 75.56 | 1,942 | 146,738 | 110,237 | 112.2 K to 110.2 K (-1.73 %) |
Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 25,000 | 86,000 | 112,179 | 87.2 K to 112.2 K (+28.68 %) |
Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 25,000 | 86,000 | 194,663 | |
Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 25,000 | 86,000 | 219,663 | |
Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 76.45 | 5,709 | 436,447 | 87,179 | 92.9 K to 87.2 K (-6.15 %) |
Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 75.28 | 19,291 | 1,452,188 | 92,888 | 112.2 K to 92.9 K (-17.20 %) |
Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 25,000 | 86,000 | 112,179 | 87.2 K to 112.2 K (+28.68 %) |
Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 84.41 | 200 | 16,882 | 87,179 | 87.4 K to 87.2 K (-0.23 %) |
Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.74 | 1,100 | 91,011 | 87,379 | 88.5 K to 87.4 K (-1.24 %) |
Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.05 | 10,800 | 886,129 | 88,479 | 99.3 K to 88.5 K (-10.88 %) |
Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.92 | 4,400 | 356,061 | 99,279 | 103.7 K to 99.3 K (-4.24 %) |
Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 79.73 | 1,643 | 130,990 | 103,679 | 105.3 K to 103.7 K (-1.56 %) |
Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 78.70 | 6,857 | 539,673 | 105,322 | 112.2 K to 105.3 K (-6.11 %) |
Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 25,000 | 86,000 | 112,179 | 87.2 K to 112.2 K (+28.68 %) |